Fundz

Gpn Vaccines reported raising $3.5 Million in an initial SEC Form D filing, from an offering of $10 Million

PRIVATEJan 28, 2026$3.5M of $10M raised

Amount Raised

$3.5 Million

$3.5 Million sold, per SEC Form D (first sale Dec 24, 2025)

Round Type

Venture

YarralumlaBiotechnology

Quick answer

GPN Vaccines raised $3.5 Million in a funding round, dated December 24, 2025. GPN Vaccines is based in Yarralumla, Australian Capital Territory, Australia.

How much did GPN Vaccines raise?
GPN Vaccines raised $3.5 Million in a funding round on December 24, 2025.
What does GPN Vaccines do?
GPN Vaccines is an Adelaide-based biotechnology company founded in 2017.
Where is GPN Vaccines based and how big is it?
GPN Vaccines is based in Yarralumla, Australian Capital Territory, Australia. Fundz records about 36 employees.
Who are the decision-makers at GPN Vaccines?
Fundz holds 4 contacts at GPN Vaccines, including the Director, International (Asia). Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as GPN Vaccines that raised within 45 days of this round, from Fundz verified event records.

  • Angitia Biopharmaceuticals raised $130M (Series D) on February 6, 2026.
  • Khaya Biosciences raised $200K (Pre-Seed) on February 5, 2026.
  • Innocent Meat raised $7M (Funding Round) on February 5, 2026.
  • NuVision Biotherapies raised $6.6M on February 5, 2026.
  • Evergreen Select raised $6M on February 4, 2026.
  • Expert Intelligence raised $4.7M (Seed) on February 4, 2026.

Who to call at GPN Vaccines, and when

A new round usually means GPN Vaccines is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GPN Vaccines raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GPN Vaccines, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GPN Vaccines. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GPN Vaccines

Location

Yarralumla, Australian Capital Territory, Australia

About

GPN Vaccines is an Adelaide-based biotechnology company founded in 2017. The company is focused on developing a novel, whole-cell vaccine to provide broad-spectrum protection against streptococcus pneumoniae, a bacterial pathogen responsible for illnesses such as sinusitis, life-threatening pneumonia, middle ear infection, and sepsis in the very young and elderly.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GPN Vaccines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsJosephine, Director, International (Asia) hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for GPN Vaccines's next move

See what Strategic adds

GPN Vaccines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.